MarketBeat Instant News Alerts 2 hours agoPalo Alto Networks (PANW) Projected to Post Quarterly Earnings on TuesdayMarketBeatPalo Alto Networks (NASDAQ:PANW) will be releasing its Q3 2026 earnings after the market closes on Tuesday, June 2. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-6-2-palo-alto-networks-inc-stock/)NASDAQ:PANWRead Palo Alto Networks (PANW) Projected to Post Quarterly Earnings on Tuesday2 hours agoConstellium (NYSE:CSTM) Stock Price Passes Above Two Hundred Day Moving Average - Time to Sell?MarketBeatConstellium (NYSE:CSTM) Stock Price Crosses Above 200 Day Moving Average - Time to Sell?NYSE:CSTMRead Constellium (NYSE:CSTM) Stock Price Passes Above Two Hundred Day Moving Average - Time to Sell?3 hours agoStewart Information Services (NYSE:STC) Stock Price Crosses Above 200 Day Moving Average - Should You Sell?MarketBeatStewart Information Services (NYSE:STC) Stock Price Crosses Above 200 Day Moving Average - Time to Sell?NYSE:STCRead Stewart Information Services (NYSE:STC) Stock Price Crosses Above 200 Day Moving Average - Should You Sell?3 hours agoDisc Medicine Eyes Mid-2026 Bitopertin Approval as EPP Trial Demand SurgesMarketBeatDisc Medicine (NASDAQ:IRON) Chief Executive Officer John Quisel said patient demand for the company’s bitopertin program in erythropoietic protoporphyria, or EPP, remains strong after the company enrolled 183 patients in the APOLLO confirmatory study, above its original target of 150. Speaking at aNASDAQ:IRONRead Disc Medicine Eyes Mid-2026 Bitopertin Approval as EPP Trial Demand Surges4 hours agoJOYY Q1 Earnings Call HighlightsMarketBeatJOYY (NASDAQ:YY) reported its strongest year-over-year revenue growth in recent years in the first quarter of 2026, as its social entertainment business returned to growth and newer businesses in advertising technology and commerce continued to scale. The company said total net revenue rose 12.4% yNASDAQ:YYRead JOYY Q1 Earnings Call Highlights5 hours agoOpus Genetics Touts Retinal Gene Therapy Pipeline, September BEST1 Data CatalystMarketBeatOpus Genetics (NASDAQ:IRD) is advancing a portfolio of gene therapies for inherited retinal diseases, with two programs already in the clinic and three more expected to enter clinical testing within the next 12 months, President Dr. Ben Yerxa said during a fireside chat at RBC Capital Markets’ 2026 NASDAQ:IRDRead Opus Genetics Touts Retinal Gene Therapy Pipeline, September BEST1 Data Catalyst Trending News1NVIDIA (NASDAQ:NVDA) Shares Down 1.9% After Analyst Downgrade2Rathbones Group PLC Acquires 489,491 Shares of ARM Holdings PLC Sponsored ADR $ARM3InterDigital Eyes $1B ARR by 2030 as 6G, AI Video and Patent Push Take Center Stage4Sandisk (NASDAQ:SNDK) Stock Price Up 10.7% - Should You Buy?5indie Semiconductor (NASDAQ:INDI) Stock Price Up 14.6% - Should You Buy?6Rocket Lab Corporation $RKLB Shares Purchased by Swedbank AB7ServiceNow (NYSE:NOW) Stock Price Down 3.5% After Analyst Downgrade8Navitas Semiconductor (NASDAQ:NVTS) Stock Price Up 6% - Time to Buy? All MarketBeat Instant News Alerts Latest News Trending News Sort By Last 24 Hours Last 3 Days Last 5 Days Last 7 Days Last 14 Days Last 30 Days Last 90 Days All Time Time Frame All Alerts Analyst Congressional Trades Consensus Corporate Buyback Corporate Event Transcript Dividend Earnings Earnings Preview Earnings Transcript Highlights Estimates Guidance Insider Trade Lockup Expiration MarketBeat List Articles Options Price SEC Filing Stock List Stock Split Alert Type Keywords 5 hours agoPPDAI Group Q1 Earnings Call HighlightsMarketBeatNYSE:FINVRead PPDAI Group Q1 Earnings Call HighlightsMay 25, 2026 6:06 PM ETIonis Pharmaceuticals Eyes Big Year With TRYNGOLZA Decision, 5 Phase 3 ReadoutsMarketBeatNASDAQ:IONSRead Ionis Pharmaceuticals Eyes Big Year With TRYNGOLZA Decision, 5 Phase 3 ReadoutsMay 25, 2026 3:03 PM ETIntel CEO Touts Balance Sheet Progress, Foundry Gains and AI CPU DemandMarketBeatNASDAQ:INTCRead Intel CEO Touts Balance Sheet Progress, Foundry Gains and AI CPU DemandMay 25, 2026 2:08 PM ETIntapp Says AI Is Driving Demand as Celeste Tackles Compliance RisksMarketBeatNASDAQ:INTARead Intapp Says AI Is Driving Demand as Celeste Tackles Compliance RisksMay 25, 2026 12:02 PM ETInovio Pharmaceuticals Shareholders Back Board as INO-3107 FDA Review AdvancesMarketBeatNASDAQ:INORead Inovio Pharmaceuticals Shareholders Back Board as INO-3107 FDA Review AdvancesMay 25, 2026 10:02 AM ETIncyte Sets Mid-Year Phase 3 Trial for CALR Antibody 989 as Pipeline Updates Roll OutMarketBeatNASDAQ:INCYRead Incyte Sets Mid-Year Phase 3 Trial for CALR Antibody 989 as Pipeline Updates Roll OutMay 25, 2026 7:04 AM ETLexinFintech Q1 Earnings Call HighlightsMarketBeatNASDAQ:LXRead LexinFintech Q1 Earnings Call HighlightsMay 25, 2026 5:33 AM ETWestover Capital Advisors LLC Sells 28,500 Shares of Encompass Health Corporation $EHCMarketBeatNYSE:EHCRead Westover Capital Advisors LLC Sells 28,500 Shares of Encompass Health Corporation $EHCMay 25, 2026 5:33 AM ETWestover Capital Advisors LLC Takes Position in BrightSpring Health Services, Inc. $BTSGMarketBeatNASDAQ:BTSGRead Westover Capital Advisors LLC Takes Position in BrightSpring Health Services, Inc. $BTSGMay 25, 2026 5:33 AM ETWestover Capital Advisors LLC Trims Stock Position in AutoZone, Inc. $AZOMarketBeatNYSE:AZORead Westover Capital Advisors LLC Trims Stock Position in AutoZone, Inc. $AZOMay 25, 2026 5:33 AM ETT-Mobile US, Inc. $TMUS Stake Lowered by Westover Capital Advisors LLCMarketBeatNASDAQ:TMUSRead T-Mobile US, Inc. $TMUS Stake Lowered by Westover Capital Advisors LLCMay 25, 2026 5:33 AM ETWestover Capital Advisors LLC Acquires Shares of 62,478 Interface, Inc. $TILEMarketBeatNASDAQ:TILERead Westover Capital Advisors LLC Acquires Shares of 62,478 Interface, Inc. $TILEMay 25, 2026 5:33 AM ETWestover Capital Advisors LLC Buys Shares of 49,858 CarGurus, Inc. $CARGMarketBeatNASDAQ:CARGRead Westover Capital Advisors LLC Buys Shares of 49,858 CarGurus, Inc. $CARGMay 25, 2026 5:33 AM ETServiceNow, Inc. $NOW Shares Purchased by Westover Capital Advisors LLCMarketBeatNYSE:NOWRead ServiceNow, Inc. $NOW Shares Purchased by Westover Capital Advisors LLCMay 25, 2026 5:33 AM ETWestover Capital Advisors LLC Decreases Stock Holdings in EMCOR Group, Inc. $EMEMarketBeatNYSE:EMERead Westover Capital Advisors LLC Decreases Stock Holdings in EMCOR Group, Inc. $EMEMay 25, 2026 5:33 AM ETWestover Capital Advisors LLC Increases Position in Netflix, Inc. $NFLXMarketBeatNASDAQ:NFLXRead Westover Capital Advisors LLC Increases Position in Netflix, Inc. $NFLXMay 25, 2026 5:33 AM ETWestover Capital Advisors LLC Sells 2,905 Shares of Celestica, Inc. $CLSMarketBeatNYSE:CLSRead Westover Capital Advisors LLC Sells 2,905 Shares of Celestica, Inc. $CLSMay 25, 2026 5:33 AM ETZeno Equity Partners LLP Trims Stake in Amphenol Corporation $APHMarketBeatNYSE:APHRead Zeno Equity Partners LLP Trims Stake in Amphenol Corporation $APHMay 25, 2026 5:33 AM ETZeno Equity Partners LLP Invests $12.43 Million in Visa Inc. $VMarketBeatNYSE:VRead Zeno Equity Partners LLP Invests $12.43 Million in Visa Inc. $VMay 25, 2026 5:33 AM ETVan Cleef Asset Management Inc Acquires New Holdings in Intel Corporation $INTCMarketBeatNASDAQ:INTCRead Van Cleef Asset Management Inc Acquires New Holdings in Intel Corporation $INTCMay 25, 2026 5:25 AM ETVan Cleef Asset Management Inc Invests $1.28 Million in Tesla, Inc. $TSLAMarketBeatNASDAQ:TSLARead Van Cleef Asset Management Inc Invests $1.28 Million in Tesla, Inc. $TSLAMay 25, 2026 5:25 AM ETVan Cleef Asset Management Inc Decreases Stock Position in The Walt Disney Company $DISMarketBeatNYSE:DISRead Van Cleef Asset Management Inc Decreases Stock Position in The Walt Disney Company $DISMay 25, 2026 5:25 AM ETVan Cleef Asset Management Inc Decreases Stake in McCormick & Company, Incorporated $MKCMarketBeatNYSE:MKCRead Van Cleef Asset Management Inc Decreases Stake in McCormick & Company, Incorporated $MKCMay 25, 2026 5:25 AM ETVan Cleef Asset Management Inc Reduces Position in Linde PLC $LINMarketBeatNASDAQ:LINRead Van Cleef Asset Management Inc Reduces Position in Linde PLC $LIN Featured Articles and OffersAlphabet (NASDAQ:GOOG) Stock Price Down 2.1% After Insider SellingBy MarketBeat | May 19, 2026This stock has 30 days of quiet leftFrom Behind the Markets (Ad)3 Space Infrastructure Stocks Gaining Momentum Ahead of the SpaceX IPOBy Ryan Hasson | May 20, 2026The Smart Glasses Gold Rush Is Leaving Old-School Eyewear BehindBy Jeffrey Neal Johnson | May 24, 20262 Software Stocks Turning AI Fears Into Fundamental GainsBy Dan Schmidt | May 21, 2026$30 stock to buy before Starlink goes public (WATCH NOW!)From Paradigm Press (Ad)From Zepbound to Foundayo: Lilly's Latest Results Support Oral GLP-1 OutlookBy Leo Miller | May 20, 2026Overextended, e.l.f. Beauty Is Primed to Rebound in Back HalfBy Thomas Hughes | May 22, 2026 Alert CategoriesAll AlertsAnalystCongressional TradesConsensusCorporate BuybackCorporate Event TranscriptStock ListDividendEarningsEarnings PreviewEarnings Transcript HighlightsEstimatesGuidanceInsider TradeLockup ExpirationMarketBeat List ArticlesOptionsPriceSEC FilingStock Split Page 1 of 229 1234567 Earlier › Earliest » Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
